| ACNFP |
Advisory Committee on Novel Foods and Processes |
| ADI |
Acceptable daily intake |
| ADME |
Absorption, Distribution, Metabolism and Excretion |
| AOAC |
Association of Official Analytical Chemists |
| ARfD |
Acute reference dose |
| aw |
Water activity |
| bw |
Body weight |
| CAS |
Chemical Abstracts Service |
| CBD |
Cannabidiol |
| CBDV |
Cannabidivarin |
| CBDVA |
Cannabidivarinic Acid |
| CBG |
Cannabigerol |
| CBN |
Cannabinol |
| Cmax |
Peak serum concentration |
| COT |
Committee on Toxicity |
| CFU |
Colony forming unit |
| DSC |
Differential scanning calorimetry |
| EC |
European Commission |
| EDA |
Energy dispersive X-ray |
| EFSA |
European Food Safety Authority |
| EMA |
Environmental Medicines Agency |
| EU |
European Union |
| FDA |
Food and Drug Administration (USA) |
| FSA |
Food Standards Agency |
| FSS |
Food Standards Scotland |
| FTIR |
Fourier-transform infrared spectroscopy |
| GC |
Gas chromatography |
| GLP |
Good Laboratory Practice |
| HACCP |
Hazards Analysis and Critical Control Points |
| HPLC |
High-performance liquid chromatography |
| HS |
Headspace |
| ICP-MS |
Inductively coupled plasma mass spectrometry |
| LC-MS |
Liquid chromatography-mass spectrometry |
| LOAEL |
Lowest observable adverse effect level |
| LOD |
Limit of Detection |
| LOQ |
Limit of quantification |
| MS |
Mass spectrometry |
| ND |
Not determined |
| NOAEL |
No observed adverse effect level |
| NM |
Not measured |
| OECD |
Organisation for Economic Co-operation and Development |
| Ph.Eur |
European Pharmacopeia |
| TGA |
Thermogravimetric analysis |
| Tmax |
Time to maximum concentration |
| USP |
United States Pharmacopeia |
| UV |
Ultraviolet |
| XRD |
X-ray diffraction |